Jonathan Monson - 01 Mar 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
01 Mar 2023
Net transactions value
-$168,865
Form type
4
Filing time
02 Mar 2023, 15:59:26 UTC
Previous filing
22 Feb 2023
Next filing
31 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $64,450 +5,000 +14% $12.89* 39,868 01 Mar 2023 Direct F1
transaction BSX Common Stock Sale $233,315 -5,000 -13% $46.66 34,868 01 Mar 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Stock Option (Right to Buy) Options Exercise $0 -5,000 -50% $0.000000 5,000 01 Mar 2023 Common Stock 5,000 $12.89 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2 Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.488 to $46.78, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Grant to the reporting person on December 1, 2014, of an option to purchase 17,901 shares of common stock.